Market Access for CNS Therapeutics Summit 2025

 

The Market Access for CNS Therapeutics Summit is the forum dedicated to promoting earlier commercial conversations to succeed in establishing new therapies for neurodegeneration, mental health, neuromuscular disorders, and more.

With 16+ expert speakers and cutting-edge sessions on biomarker reimbursement, patient navigation, and umbrella trials, attendees will gain practical insights to overcome the growing complexity of market access in CNS. Don’t miss the most targeted opportunity to stay competitive and unlock earlier patient access.

Join pioneering biotech and pharma companies, including Roche, Abbvie, Eli Lilly, Neurolief, Lumanity and Labcorp, healthcare providers, and commercial and private payers this September in Boston.

 

More Info

---

---